drugset / Trial / NCT05669885
Hypersensitivity to Phosphodiesterase 5 Inhibition in Post-Traumatic Headache
RandomizedCrossoverQuadruple-blindBasic science
Summary
To investigate whether sildenafil (phosphodiesterase 5 inhibitor) induces migraine-like headache in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).
Timeline
- Start
- 2023-01-02
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 100 mg | Oral |